Gentili Pharma has signed a distribution agreement with STADA Pharma CZ, establishing them as the official partner for the commercialization of Instanyl and Matrifen in the Czech Republic. Under the terms of the agreement, STADA Pharma CZ will be responsible for promotional, sales, and distribution activities for the two products throughout the country.

This partnership establishes a structured collaboration for Gentili Pharma within a strategic market, leveraging STADA Pharma CZ's established local presence and expertise to ensure the successful distribution and availability of these important medicines.